QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 22, no. 3 (2003): 31-41
doi: 10.1377/hlthaff.22.3.31
© 2003 by Project HOPE
 
New Online
 * Pay Cuts For Medicare Docs
 * Access To Care Woes
 * Public Coverage More Efficient
 * Empowering Consumers
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (11)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Maynard, A.
* Articles by Bloor, K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Maynard, A.
* Articles by Bloor, K.
Related Collections
* International Issues
* Legal/Regulatory Issues
* Pharmaceuticals

Prescription Drugs

Dilemmas In Regulation Of The Market For Pharmaceuticals

Alan Maynard and Karen Bloor

What can be learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies’ cost-effectiveness. There is an emerging consensus that reimbursement in public and private health care systems should be informed by evidence of the cost-effectiveness of treatments and that utilization should be constrained by budget caps and information systems. Whatever the policy chosen, evaluation is as essential as it is rare.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
N. K. Choudhry and A. S. Detsky
A Perspective on US Drug Reimportation
JAMA, January 19, 2005; 293(3): 358 - 362.
[Full Text] [PDF]


Home page
Journal of Health Politics, Policy and LawHome page
W. M. Sage
Unfinished Business: How Litigation Relates to Health Care Regulation
Journal of Health Politics Policy and Law, April 1, 2003; 28(2-3): 387 - 420.
[Abstract] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2003 Project HOPE–The People-to-People Organization
Terms and Policies